| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study
|
Delaloge, S.
|
|
|
25 |
6 |
p. 1152-1158
|
article
|
| 2 |
A genetic model for gallbladder carcinogenesis and its dissemination
|
Barreto, S.G.
|
|
|
25 |
6 |
p. 1086-1097
|
article
|
| 3 |
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
|
Bines, J.
|
|
|
25 |
6 |
p. 1079-1085
|
article
|
| 4 |
Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer
|
Han, X.
|
|
|
25 |
6 |
p. 1158-1164
|
article
|
| 5 |
Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies
|
Shimazu, T.
|
|
|
25 |
6 |
p. 1228-1233
|
article
|
| 6 |
Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway
|
Kalager, M.
|
|
|
25 |
6 |
p. 1137-1143
|
article
|
| 7 |
Core business, future direction, and the 10-bar target
|
Tabernero, J.
|
|
|
25 |
6 |
p. 1077-1078
|
article
|
| 8 |
Corrections to “Selection of oncology medicines in low- and middle-income countries”
|
|
|
|
25 |
6 |
p. 1251
|
article
|
| 9 |
Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies
|
Genkinger, J.M.
|
|
|
25 |
6 |
p. 1106-1115
|
article
|
| 10 |
Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer
|
Hirabayashi, S.
|
|
|
25 |
6 |
p. 1179-1184
|
article
|
| 11 |
Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer
|
Tong, L.
|
|
|
25 |
6 |
p. 1234-1242
|
article
|
| 12 |
Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications
|
Suraokar, M.B.
|
|
|
25 |
6 |
p. 1184-1192
|
article
|
| 13 |
GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma
|
Yang, C.Z.
|
|
|
25 |
6 |
p. 1215-1222
|
article
|
| 14 |
Hemorrhagic cystitis in patients treated with cabazitaxel: a radiation recall syndrome?
|
Grellety, T.
|
|
|
25 |
6 |
p. 1248-1249
|
article
|
| 15 |
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT
|
Hochster, H.S.
|
|
|
25 |
6 |
p. 1172-1178
|
article
|
| 16 |
Incidence of bowel perforation in gastrointestinal lymphomas by location and histology
|
Vaidya, R.
|
|
|
25 |
6 |
p. 1249-1250
|
article
|
| 17 |
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
|
Swain, S.M.
|
|
|
25 |
6 |
p. 1116-1121
|
article
|
| 18 |
Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer
|
Kwon, M.
|
|
|
25 |
6 |
p. 1208-1214
|
article
|
| 19 |
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer †
|
Gonzalez-Angulo, A.M.
|
|
|
25 |
6 |
p. 1122-1127
|
article
|
| 20 |
Optimal treatment of early-stage ovarian cancer
|
Collinson, F.
|
|
|
25 |
6 |
p. 1165-1171
|
article
|
| 21 |
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database
|
Cassier, P.A.
|
|
|
25 |
6 |
p. 1222-1228
|
article
|
| 22 |
Pain related to cancer treatments and diagnostic procedures: a no man's land?
|
Ripamonti, C.I.
|
|
|
25 |
6 |
p. 1097-1106
|
article
|
| 23 |
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
|
Bonnefoi, H.
|
|
|
25 |
6 |
p. 1128-1136
|
article
|
| 24 |
Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
|
Leung, S.F.
|
|
|
25 |
6 |
p. 1204-1208
|
article
|
| 25 |
Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209
|
Kitamura, H.
|
|
|
25 |
6 |
p. 1192-1198
|
article
|
| 26 |
Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance †
|
Daniëls, L.A.
|
|
|
25 |
6 |
p. 1198-1203
|
article
|
| 27 |
Survival of women with inflammatory breast cancer: a large population-based study †
|
Dawood, S.
|
|
|
25 |
6 |
p. 1143-1151
|
article
|
| 28 |
Table of Contents
|
|
|
|
25 |
6 |
p. ii-iv
|
article
|
| 29 |
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM)
|
Pedrazzoli, P.
|
|
|
25 |
6 |
p. 1243-1247
|
article
|
Journal description